Global Personalized Cancer Vaccine Market Opportunity & Clinical Innovation Trend Outlook 2024 - ResearchAndMarkets.com

DUBLIN--()--The "Global Personalized Cancer Vaccine Market Opportunity & Clinical Innovation Trend Outlook 2024" report has been added to ResearchAndMarkets.com's offering.

Global Personalized Cancer Vaccine Market Opportunity & Clinical Innovation Trend Outlook 2024 Report Highlights:

  • General Working Mechanism of Personalized Cancer Vaccine
  • Relevance of Biomarkers In Personalized Vaccines
  • Developmental Cost Analysis of a Personalized Cancer Vaccine
  • Advancements in the Personalized Cancer Vaccine
  • Personalized Cancer Vaccine Market Analysis by Cancer

The report on the personalized cancer vaccine market provides a detailed insight into the current status of the segment with special emphasis on the clinical innovations governing the market. The report also highlights the clinical relevance of personalized cancer vaccine, trends and recent advances that will impact the growth of the market. Overall, the report concludes with future projections regarding the personalized cancer vaccine segment which shows an exponential growth by 2024.

The cancer therapeutic segment is currently anticipated to be worth more than US$ 100 Billion. With rapid advancement in the immunotherapy segment, almost 60% of the market will be dominated by some immuno-therapeutic product by 2024, thus forming the backbone of the global cancer therapy market. This presents an excellent opportunity for an innovative product such as the personalized cancer vaccine.

The US is currently the leading market for personalized cancer vaccine, followed by the European Union. The early launch and impressive adoption of existing preventive and therapeutic cancer vaccine indicates that the US is bound to remain the dominant market for at least a decade. The involvement of regions like Japan, South Korea and China indicates it to be a competitive market in the future. Most of the cancer vaccines under development are focused on the treatment of deadly and highly prevalent cancers such as Melanoma, breast cancer, lung cancer, prostate cancer and Cervical Cancer.

Key Topics Covered:

1. Personalized Cancer Vaccine: Promising Cancer Therapeutics of the Future

2. General Working Mechanism of Personalized Cancer Vaccine

3. Relevance of Biomarkers In Personalized Vaccines

4. Manufacturing Process & Cost Analysis of a Personalized Cancer Vaccine

5. Current Market Trends & Advancements in the Personalized Cancer Vaccine Segment

6. Global - Personalized Cancer Vaccine Market Analysis by Cancer Type

7. New Avenues & Opportunities for Personalized Cancer Vaccine Development

8. Porter's Five Force Analysis of the Personalized Cancer Vaccine Market

9. Driving Factors of the Personalized Cancer Vaccine Market

10. Major Challenges to the Personalized Cancer Vaccine Market

11. Global Personalized Cancer Vaccine Market Future Outlook

12. Competitive Landscape

  • Advaxis Inc.
  • Avax Technologies
  • BioNtech AG
  • Celldex
  • CureVac AG
  • Genetech
  • Genocea
  • Gristone Oncology
  • ISA Pharmaceuticals
  • Merck
  • Moderna Therapeutics
  • Neon Therapeutics
  • Personalis

For more information about this report visit https://www.researchandmarkets.com/research/33gq6m/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cancer Vaccines

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cancer Vaccines